Patents by Inventor Jingrong Wang

Jingrong Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200341648
    Abstract: Embodiments of the present disclosure a method, device and computer program product for storage management. The method comprises: determining, from a storage system, a plurality of storage areas corresponding to a plurality of files; selecting, from the plurality of storage areas, a pair of first storage area and second storage area, both the first storage area and the second storage area having non-empty available space; moving at least part of data stored in used space of the first storage area to available space of the second storage area; and in response to determining that the used space of the first storage area becomes empty after the moving, releasing the first storage area. In this way, the storage space can be effectively released and the storage efficiency is accordingly improved.
    Type: Application
    Filed: September 30, 2019
    Publication date: October 29, 2020
    Applicant: EMC IP Holding Company LLC
    Inventors: Jingrong ZHAO, Qingxiao ZHENG, Kerry LI, Yi WANG
  • Publication number: 20200327109
    Abstract: Embodiments of the present disclosure relate to a method, an electronic device and a computer program product for a creating metadata index. The method disclosed herein comprises: generating a first-level index to index a metadata item; inserting a first indication into the first-level index to indicate a position of the metadata item in a set of metadata; generating a second-level index to index a set of first-level indexes; and inserting a second indication into the second-level index to indicate a set of positions of the set of metadata. In this way, embodiments of the present disclosure can create an index structure which can indicate the position of the metadata item, so as to rapidly determine the position of the metadata item.
    Type: Application
    Filed: July 12, 2019
    Publication date: October 15, 2020
    Inventors: Jingrong Zhao, Qingxiao Zheng, Yi Wang
  • Patent number: 10766869
    Abstract: The invention relates to triazole compounds of formula I and I? or pharmaceutically acceptable salts thereof, useful as modulators of demyelinating diseases: The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention, methods of using the compositions and kits thereof in the treatment of various demyelinating and neurodegenerative diseases, including multiple sclerosis.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: September 8, 2020
    Assignee: VERTEX PHARMACEUTCALS INCORPORATED
    Inventors: Robert J. Davies, Jingrong Cao, Meghan Elise Cockerill, Philip Noel Collier, Elisabeth Doyle, James Daniel Frantz, Huai Gao, Brian Anthony Goldman, Ronald Lee Grey, Jr., Anne-Laure Grillot, Wenxin Gu, James A. Henderson, Raul Eduardo Krauss, Adrianne Lynn Kolpak, Yusheng Liao, Sanjay Shivayogi Magavi, David Messersmith, Albert Charles Pierce, Emanuele Perola, Elizabeth Jin-Sun Ryu, Joshua Syken, Jian Wang, Michael Paul DeNinno, Francois Maltais
  • Publication number: 20200044983
    Abstract: A unified distributed real-time quota limitation system limits use of shared networked resources in distributed networked environment (DNE). A dispatch center determines an amount of shared resources available to client devices in the DNE. The dispatch center determines an amount of the shared resources to allocate for use by the clients, and sends the clients one or more policies having a resource usage quota that limits the amount of the resource that the client can use. When a client receives a request to perform a task that requires a shared resource, before running the task, the client determines its own usage of the resource and terminates the task if running the task will exceed the quota limit of the shared resource.
    Type: Application
    Filed: August 28, 2018
    Publication date: February 6, 2020
    Inventors: QingXiao ZHENG, Yi WANG, JingRong ZHAO, LanJun LIAO, Haitao LI
  • Publication number: 20190220441
    Abstract: The present disclosure provides a solution for migrating data. In the solution, a migration tool first receives, from a source server, an index having index values corresponding to a plurality of files stored at the source server. The migration tool then retrieves a location of an index value corresponding to key information file in the index. The migration tool sorts the index based on the retrieved location. The migration tool processes the plurality of files based the sorted index, such that the sorted index causes the key information file to be processed last.
    Type: Application
    Filed: January 17, 2019
    Publication date: July 18, 2019
    Inventors: Yi Wang, Lei Wang, Qingxiao Zheng, Yongsheng Guo, Haitao Li, Jingrong Zhao
  • Publication number: 20190185436
    Abstract: The invention relates to triazole compounds of formula I and I? or pharmaceutically acceptable salts thereof, useful as modulators of demyelinating diseases: The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention, methods of using the compositions and kits thereof in the treatment of various demyelinating and neurodegenerative diseases, including multiple sclerosis.
    Type: Application
    Filed: October 17, 2018
    Publication date: June 20, 2019
    Inventors: Robert J. Davies, Jingrong Cao, Meghan Elise Cockerill, Philip Noel Collier, Elisabeth Doyle, James Daniel Frantz, Huai Gao, Brian Anthony Goldman, Ronald Lee Grey, JR., Anne-Laure Grillot, Wenxin Gu, James A. Henderson, Raul Eduardo Krauss, Adrianne Lynn Kolpak, Yusheng Liao, Sanjay Shivayogi Magavi, David Messersmith, Albert Charles Pierce, Emanuele Perola, Elizabeth Jin-Sun Ryu, Joshua Syken, Jian Wang, Michael Paul DeNinno, Francois Maltais
  • Patent number: 9561221
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Patent number: 9561220
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Patent number: 9561222
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Patent number: 9561219
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Patent number: 9561223
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: February 7, 2017
    Assignee: Macau University of Science and Technology
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Publication number: 20160113922
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 28, 2016
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Publication number: 20160106730
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Publication number: 20160106734
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Publication number: 20160106733
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Publication number: 20160106732
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Publication number: 20160106729
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 31, 2015
    Publication date: April 21, 2016
    Inventors: Kam Wai Wong, Yuen Kwan Law, Liang Liu, Jingrong Wang
  • Patent number: 9273088
    Abstract: The present invention provides novel ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: March 1, 2016
    Assignee: Macau University of Science and Technology
    Inventors: Jingrong Wang, Pei Luo, Hua Zhou, Wai In Chan, Liang Liu, Zhihong Jiang
  • Publication number: 20150190392
    Abstract: The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
    Type: Application
    Filed: December 8, 2014
    Publication date: July 9, 2015
    Inventors: Kam Wai WONG, Yuen Kwan LAW, Liang LIU, Jingrong WANG
  • Publication number: 20150112048
    Abstract: The present invention provides novel ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury.
    Type: Application
    Filed: October 17, 2013
    Publication date: April 23, 2015
    Applicant: Macau University of Science and Tehnology
    Inventors: Jingrong WANG, Pei LUO, Hua ZHOU, Wai In CHAN, Liang LIU, Zhihong JIANG